UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Congress Park Capital LLC

Congress Park Capital LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 15.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 1,250 shares of the healthcare conglomerate’s stock after purchasing an additional 165 shares during the quarter. Congress Park Capital LLC’s holdings in UnitedHealth Group were worth $655,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group in the fourth quarter worth about $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $32,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction dated Friday, May 16th. The shares were bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the firm’s stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 in the last three months. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $306.90 on Friday. The stock has a market capitalization of $278.40 billion, a P/E ratio of 12.85, a P/E/G ratio of 1.44 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm’s 50 day moving average is $365.09 and its 200-day moving average is $465.88.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.88%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Hsbc Global Res downgraded UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Piper Sandler cut their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a research note on Tuesday, June 3rd. Barclays lowered their price target on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday, June 2nd. Finally, HSBC reaffirmed a “reduce” rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.